Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SAVA - The Post-Biogen Post-Amyloid World For Alzheimer's Disease

SAVA - The Post-Biogen Post-Amyloid World For Alzheimer's Disease

Cassava Sciences Inc.
  • The results of future clinical trials may have some slight bearing on Biogen's stock value.
  • If several restrictions are put on the coverage of Biogen's Aduhelm, that would negatively impact the stock to some degree.
  • Biogen's stock value would drop further if others in the Alzheimer's field came up with more effective drugs.
  • There are a number of drugs in development that will likely be more effective for the treatment of Alzheimer's disease than Aduhelm.

For further details see:

The Post-Biogen, Post-Amyloid World For Alzheimer's Disease
Stock Information
Company Name: Cassava Sciences Inc.
Stock Symbol: SAVA
Market: NASDAQ
Website: cassavasciences.com
Menu
SAVA SAVA Quote SAVA Short SAVA News SAVA Articles SAVA Message Board
Get SAVA Alerts

News, Short Squeeze, Breakout and More Instantly...